MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$20,466,000
Net Income
$5,218,000
Net Profit Margin
25.50%
EPS
$0.41
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Revenue
20,466,000
21,979,000
21,202,064
20,409,400
Cost of revenue
5,306,000
5,165,000
4,707,756
4,454,408
Gross profit
15,160,000
16,814,000
16,494,308
15,954,992
General and administrative
3,866,000
4,569,000
4,355,636
4,279,993
Sales and marketing
4,246,000
4,052,000
4,630,560
4,009,640
Research and development
657,000
956,000
674,362
877,362
Total operating expenses
8,769,000
9,577,000
9,660,558
9,166,995
Income from operations
6,391,000
7,237,000
6,833,750
6,787,997
Other income, net
497,000
532,000
463,976
539,247
Income before provision for income taxes
6,888,000
7,769,000
7,297,726
7,327,244
Provision for income tax expense
1,670,000
1,951,000
1,721,074
1,553,283
Net income
5,218,000
5,818,000
5,576,652
5,773,961
Basic EPS
0.41
0.46
0.44
0.45
Diluted EPS
0.41
0.45
0.43
0.45
Basic Average Shares
12,784,000
12,783,000
12,720,812
12,715,872
Diluted Average Shares
12,872,000
12,870,000
12,860,077
12,835,408
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Revenue
$20,466,000
(0.28%↑ Y/Y)
Gross profit
$15,160,000
(-4.98%↓ Y/Y)
Cost of revenue
$5,306,000
(19.12%↑ Y/Y)
Income from operations
$6,391,000
(-5.85%↓ Y/Y)
Other income, net
$497,000
(-7.83%↓ Y/Y)
Total operating
expenses
$8,769,000
(-4.34%↓ Y/Y)
Income before
provision for income taxes
$6,888,000
(-5.99%↓ Y/Y)
Sales and marketing
$4,246,000
(5.89%↑ Y/Y)
General and
administrative
$3,866,000
(-9.67%↓ Y/Y)
Research and development
$657,000
(-25.12%↓ Y/Y)
Net income
$5,218,000
(-9.63%↓ Y/Y)
Provision for income tax
expense
$1,670,000
(7.51%↑ Y/Y)
Buy us a coffee
IRADIMED CORP (IRMD)
IRADIMED CORP (IRMD)